Search PubMed⌕ Search

Biomedical subjects

T Liu

Publications and source records attributed to T Liu.

At least 487 records · Page 27Linked to original sources

Frequency of lambda light chain subtypes in mouse antibodies to the 2,4-dinitrophenyl (DNP) group.

Of the three lambda chain subtypes made by inbred mice, chains of the lambda 1 subtype are much more frequent than those of the other subtypes (lambda 2,lambda 3) in antibodies (Ab) to those few antigenic structures that are known to elicit responses, in which lambda chains are the predominant type of light chain [(4-hydroxy-3-nitrophenyl)acetyl (NP) and dextran]. The reason for the frequency differences are not understood, and the large difference between the lambda 1 and lambda 3 frequencies is particularly puzzling, because in nearly all (about 95%) chains of these subtypes the N-terminal 97 or 98 amino acids are endoded by the same V lambda-gene segment. In an effort to identify an Ab response that has different lambda subtype frequencies, we analyzed the light chains of the Ab made by BALB/c and B6 mice in response to 2,4-dinitrophenylated chicken gamma globulin (DNP-CGG). We found that approximately 40% of the elicited anti-DNP molecules had lambda chains and of these approximately 40% were of the lambda 2 or lambda 3 subtype. Polyacrylamide gel electrophoresis indicated that the lambda 2 and lambda 3 chains were about equally abundant. Similar lambda subtype frequencies were found in the anti-DNP Ab produced by the hybridoma made with spleen cells from the same immunized mice. In the anti-DNP Ab elicited by DNP-CGG and in the anti-NP Ab elicited by NP-CGG the different lambda subtype frequencies (lambda 1/lambda 2 + lambda 3 = ca. 1.0-1.5 in anti-DNP and ca. 30 in anti-NP) were unaffected by immunizing mice with each of these antigens alone or with a mixture of the two. This finding, though preliminary, suggests that isotype-specific regulatory T cells are not responsible for the markedly different lambda subtype frequencies in anti-DNP and anti-NP Ab.

2,4-Dinitrophenol↗

Effect of vitamin E supplementation on serum and high-density lipoprotein-cholesterol in renal patients on maintenance hemodialysis.

A significant increase in high-density lipoprotein-cholesterol after the ingestion of short-term megadoses of vitamin E has been documented in the recent literature. No attempt has been made to examine the effect of vitamin E supplementation on the serum lipids in chronic renal patients undergoing maintenance hemodialysis. This patient group typically exhibits subnormal high-density lipoprotein-cholesterol levels which may be a factor responsible for their increased mortality rate from atherosclerosis. In the present study, seven male renal patients on dialysis were given 600 IU of vitamin E daily for 4 wk. The level of total, free, and esterified cholesterol and triglyceride in whole serum and high-density lipoprotein were measured pre- and postregimen. No significant change was noted in any of the parameters examined for the group as a whole. Our results suggest that short-term high-dose vitamin E ingestion is unlikely to benefit the majority of renal patients on maintenance hemodialysis in regards to their circulating levels of high-density lipoprotein-cholesterol.

Adult↗

Characterization of the individual phospholipids and their fatty acids in serum and high-density lipoprotein of the renal patient on long-term maintenance hemodialysis.

This study characterized the individual phospholipids within total serum and HDL in the renal patient on long-term maintenance hemodialysis relative to matched controls. The fatty acid composition of these individual phospholipids was also determined by using TLC and gas-liquid chromatography in combination. In agreement with previous findings, our patient group had HDL-cholesterol levels 36% below and total phospholipid levels 30% lower than matched controls. Total serum PE but not HDL-PE was significantly elevated (by 30%) in the serum of the patient group due to a rise in diacyl PE. Significantly reduced HDL-SPH levels (by 41%) and a 31% decrease in HDL-PC levels were noted in the patient group. Considerable differences in the individual fatty acids (as weight percent) of the patient vs. control groups were observed. The percent of 16:0 (palmitate) and 18:0 (stearate) was significantly elevated in the PE of the patient group whereas 18:1 (octadecenoate) was generally elevated in all phospholipids. The weight percent of 18:2 (linoleate) was moderately higher in the PE and Pl of the patient group. Absolute levels of selected fatty acids in PC were generally depressed in the patient HDL relative to control, although significantly so only in the case of 16:0 and 20:4 (arachidonate). In keeping with the total PE levels in whole serum, all fatty acids were elevated in the patient group relative to controls. These results indicate that alterations in certain individual phospholipids and their fatty acids exist in renal patients on dialysis compared to matched controls.

Adult↗

The aldolase-binding site of the human erythrocyte membrane is at the NH2 terminus of band 3.

Band 3 is the predominant membrane-spanning polypeptide and the mediator of anion transport in the human erythrocyte. In addition, it provides the sites of association for fructose 1,6-bisphosphate aldolase and other cytoplasmic proteins with the membrane. The aldolase-binding activity of water-soluble fragments of band 3 was measured by their inhibition of aldolase catalytic activity and by their displacement of aldolase from ghosts. At saturation, the binding of one band 3 or certain of its fragments per aldolase molecule partially inhibited the catalytic activity and band 3 binding of the unliganded subunits of the tetramer through an apparently cooperative mechanism. An NH2-terminal 23,000-dalton fragment generated by S-cyanylation of the cytoplasmic pole of band 3 was approximately 20% as avid in binding aldolase as was native band 3. Several fragments cleaved from the NH2-terminal portion of the 23,000-dalton peptide by trypsin, mild acid hydrolysis, and cyanogen bromide digestion all bound aldolase, while fragments from the rest of the polypeptide were essentially inactive. The first 31 residues of band 3 contained 16 Asp plus Glu, no basic residues, and a blocked alpha-amino terminus. The highly acidic composition of this region is consistent with the strongly electrostatic character of the interaction between band 3 and aldolase, presumably at the strongly basic catalytic center of the enzyme. We conclude that the NH2-terminal region of band 3 bears the membrane-binding site for aldolase.

Amino Acids↗

Effect of prolactin on the secretion of dehydroepiandrosterone (DHEA), its sulfate (DHEA-S), and cortisol by the human fetal adrenal in vitro.

The effect of prolactin on the secretions of dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S) as well as that of cortisol were studied in vitro in order to investigate the possible regulatory role of prolactin on steroidogenesis of the human fetal adrenal at mid-gestational age. The addition of 0.5 microgram/ml of human prolactin to the incubation medium produced a significant (P less than 0.05) increase in DHEA, DHEA-S, and cortisol secretion. These results indicate that prolactin has a regulatory role in steroidogenesis in the human fetal adrenal at mid-gestation.

Adrenal Glands↗

Radiation therapy of nasopharyngeal carcinoma.

Carcinoma of the nasopharynx is one of the most frequent malignant tumors in the southern parts of China. A total of 3 263 cases treated with irradiation in the course of the thirty years since the Liberation have been analysed retrospectively. The 5-year survival rate has risen from 27.7 per cent for cases treated during 1955 to 1960 to 54 per cent for those treated in 1973. The technique of irradiation is described, emphasizing the importance of suitable techniques for the treatment of the cervical lymph nodes. The value of elective irradiation of cervical regions not involved clinically is elucidated. Finally, the causes of failure of treatment are discussed.

Cobalt Radioisotopes↗

Arrangement of glucose residues in the lipid-linked oligosaccharide precursor of asparaginyl oligosaccharides.

The lipid-linked oligosaccharide synthesized in vitro, in the presence of 1.0 microM UDP-[3H]Glc, GDP-[14C]Man, and UDP-GlcNAc has been isolated and the structure of the oligosaccharide has been analyzed. The oligosaccharide contains 2 N-acetylglucosamine, 9 mannose, and 3 glucose residues. The N-acetylglucosamine residues are located at the reducing terminus. The 3 glucose residues are arranged in a linear order at one of the nonreducing termini in the sequence Glc 1,2--Glc 1,3--Glc--(Man)9 (GlcNAc)2. The structural analysis was made possible largely by the availability of glucosidase preparations of fungal anad microsomal origin which remove glucose residues from the oligosaccharide without releasing mannose residues.

Asparagine↗

Effects of UDP-glucose addition on the synthesis of mannosyl lipid-linked oligosaccharides by cell-free fibroblast preparations.

The pattern of mannosyl lipid-linked oligosaccharides synthesized by cell-free enzyme preparations from cultured fibroblasts is altered substantially when 0.2 muM UDP-glucose is added to the incubation medium. Inclusion of UDP-glucose results in the appearance of a new labeled oligosaccharide, which is 1 or 2 glycose units larger than the lipid-linked oligosaccharide synthesized in the presence of only GDP-mannose (2 muM) and UDP-N-acetylglucosamine (20 muM). Label from UDP-[3H]glucose is incorporated into the same larger oligosaccharide size class. The results can be explained most easily by assuming that the new mannosyl lipid-linked oligosaccharide contains 1 or 2 glucose residues in addition to 5 to 6 mannose residues. The results are compatible with the recent finding by Spiro et al. (Spiro, M.J., Spiro, R.G., and Bhoyroo, V.D. (1976) Fed Proc. 35, 1375; Spiro M.J. Spiro, R.G., and Bhoyroo, V.D. (1976) J. Biol. Chem. 251, 6400-6408; Spiro, R.G., and Spiro, M.J. AND Bhoyroo, V.D. (1976) J. Biol. Chem. 251, 6409-6419; Spiro, M.J., Spiro R.G., and Bhoyroo, V.D. (1976) J. Biol. Chem. 251, 6420-6425) that naturally occurring mannosyl lipid-linked oligosaccharides contain glucose. In addition to being incorporated into lipid oligosaccharides, glucose residues are also incorporated into endogenous glycoproteins. Incorporation of glucose into glycoproteins that give rise to pronase glycopeptides of the typical asparagine-linked size classes is almost completely dependent on the presence of GDP-mannose.

Cell Line↗

The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid.

The isoprostanes (IsoPs) are a unique series of prostaglandin-like compounds formed in vivo from the free radical-catalyzed peroxidation of arachidonic acid. This review summarizes our current knowledge regarding these compounds. Novel aspects of the biochemistry and bioactivity of IsoPs are detailed and methods by which these compounds are analyzed are discussed. A considerable portion of this review deals with the utility of measuring IsoPs as markers of oxidant injury in human diseases particularly in association with risk factors that predispose to atherosclerosis, a condition in which excessive oxidative stress has been causally implicated.

Animals↗

Direct synthesis and characterization of site-specific adenosyl adducts derived from the binding of a 3,4-dihydroxy-1,2-epoxybenzo[c]phenanthrene stereoisomer to an 11-mer oligodeoxyribonucleotide.

Site-specifically modified oligonucleotides were obtained in milligram quantities by reacting racemic 3t,4r-dihydroxy-1,2t-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene (B[c]PhDE-2, or anti-B[c]PhDE) with the single deoxyadenosine (dA) residue in the oligodeoxynucleotide d(CTCTCACTTCC). Enzyme digestion of the covalently modified oligonucleotides with the exonuclease spleen phosphodiesterase yielded covalently linked B[ca]PhDE-N6-deoxyadenosyl monophosphate (dAMP) adducts. Comparisons of the reverse phase HPLC retention times and CD spectra of these B[c]PhDE-3'-dAMP mononucleotide adducts, with those of standards derived from the reaction of the enantiomers (+)- and (-)-anti-B[c]PhDE with 3'-dAMP, show that two major oligonucleotide adducts (I and II) were obtained upon reacting racemic anti-B[c]PhDE with d(CTCTCACTTCC). In oligonucleotide adduct I, the lesion is a (+)-trans-anti-B[c]PhDE-N6-dA residue, and in oligonucleotide adduct II it is a (-)-trans-anti-B[c]PhDE-N6-dA residue. These assignments were further confirmed using a standard 32P postlabeling assay of B[c]PhDE-3'-dAMP mononucleotide adducts obtained from the digestion of oligonucleotides I and II by spleen phosphodiesterase. The melting points (Tm) of duplexes of modified oligonucleotides I and II and their natural complementary strands are not affected significantly by the presence of the covalently bound benzo[c]phenanthrenyl residues. Opposite stereoselective resistance to enzyme digestion by the exonucleases snake venom phosphodiesterase and spleen phosphodiesterase is exhibited by the stereoisomeric (+)-trans- and (-)-trans-anti-B[c]PhDE-modified oligonucleotide adducts I and II; these results are consistent with the intercalative insertion of the benzo[c]phenanthrenyl residues on the 5'-side of the modified dA residue in adduct I, and its insertion on the 3'-side of the dA residue in adduct II, as observed in the duplexes by high resolution NMR techniques [Cosman et al. (1993) Biochemistry 32, 12488-12497, and Cosman et all, Biochemistry, in press.

Adenosine↗

Base sequence-dependent bends in site-specific benzo[a]pyrene diol epoxide-modified oligonucleotide duplexes.

The site specifically modified oligonucleotides 5'-d(TCCTCCTG1G2CCTCTC) (I) and 5'-d(CTATG1G2G3TATC) (II) were synthesized with single modified guanine residues at positions G1, G2, or G3, derived from the covalent binding reaction of 7R,8S-dihydroxy-9S,10R-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene ((+)-anti-BPDE) with the exocyclic amino groups of the guanine residues. In denaturing 20% polyacrylamide gels, the electrophoretic mobilities of the (+)-anti-BPDE-modified oligonucleotides I and II are slower than the mobilities of the respective unmodified oligonucleotides and independent of the positions of the BPDE-modified guanines. However, in the double-stranded forms in native 8% polyacrylamide gels, the electrophoretic mobilities of the duplexes with lesions at G2 or G3 are remarkably slower (reductions in mobilities up to approximately 40%) than to duplexes with lesions at G1 and are attributed to physical bends or flexible hinge joints at the sites of the BPDE lesions. These sequence-dependent mobility effects occur whenever the BPDE-modified guanine residues with (+)-trans-stereochemistry are flanked by unmodified G's on the 5'-side. These retarded electrophoretic mobilities are attributed to bending induced by steric hindrance effects involving the bulky 5'-flanking guanines and the pyrenyl residues that are known to point into the 5'-direction relative to the modified G [Cosman, M., et al. (1992) Proc. Natl. Acad. Sci. U.S.A. 89, 1914-1918]. These anomalous electrophoretic mobility effects are not observed in the case of (-)-anti-BPDE-modified sequences I with trans-(-)-anti-BPDE-N2-dG adduct stereochemistry.

7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide↗

A nationwide prehospital stroke survey.

OBJECTIVES: To identify deficiencies in stroke knowledge among prehospital providers. METHODS: A nationwide multiple-choice survey was sent to 689 paramedics (EMT-Ps) and 294 advanced EMTs (EMT-Is) from a random selection of the National Registry of Emergency Medical Technicians database. Of the 23 questions, five addressed demographic information, four quantity of training, five general knowledge, 6 and seven management, and two open-ended questions addressed the signs, symptoms, and risk factors of stroke. The EMT-P and EMT-I answers were compared using chi-square analysis or Fisher's exact test. RESULTS: Of the 355 (36%) respondents, 256 (72%) were EMT-Ps and 99 (28%) were EMT-Is. Virtually all the EMT-Ps (99%) and EMT-Is (98%) knew that a stroke injures the brain, but only 199 (78%) of the EMT-Ps and 47 (47%) of the EMT-Is correctly defined a transient ischemic attack (TIA) (p < 0.001). Slurred speech, weakness/ paralysis, and altered mental status were the three most commonly cited symptoms of stroke by both groups. The EMT-Ps were more likely to recognize that dextrose is potentially harmful to stroke patients [EMT-P = 216 (85%), EMT-I = 71 (72%), p = 0.005]; 169 (66%) of the EMT-Ps and 75 (76%) of the EMT-Is felt that elevated blood pressures should be lowered in the prehospital setting. Only 93 (36%) of the EMT-Ps and 22 (22%) of the EMT-Is knew that tissue plasminogen activator (tPA) must be given within three hours of symptom onset (p = 0.01). CONCLUSION: Most EMS providers are knowledgeable about the symptoms of stroke but are unaware of the therapeutic window for thrombolysis and the recommended avoidance of prehospital blood pressure reduction. In addition, further education is needed regarding TIAs.

Adult↗